Topic · page 36 of 40

Rheumatoid arthritis

Early and established rheumatoid arthritis in adults: diagnosis and prediction (clinically suspect arthralgia, people at risk), treat-to-target, conventional, biologic and targeted synthetic drugs, tapering and withdrawal, glucocorticoids, extra-articular disease and rheumatoid arthritis–associated interstitial lung disease

Briefs 1,401–1,440 of 1,564 placed here, newest publication first

Briefs in Rheumatoid arthritis

Newest publication first

Rheumatology (Oxford)6 Jan 2023
A multidisciplinary lifestyle program for rheumatoid arthritis: the ‘Plants for Joints’ randomized controlled trial
Randomized controlled trial
Rheumatology (Oxford)6 Jan 2023
Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages
Cross-sectional study
Clin Exp Rheumatol6 Jan 2023
JAK/STAT inhibition modifies the ILC1 immune response in patients with rheumatoid arthritis
Mechanistic study
Arthritis Rheumatol5 Jan 2023
Assessing the Immune Cell Subset and Genetic Mutations in Patients With Palindromic Rheumatism Seronegative for Rheumatoid Factor and Anti–Cyclic Citrullinated Peptide
Mechanistic study
RMD Open4 Jan 2023
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs)
Research article
Rheumatology (Oxford)30 Dec 2022
Janus kinase inhibitors alter NK cell phenotypes and inhibit their antitumour capacity
Mechanistic study
Rheumatology (Oxford)28 Dec 2022
Multibiomarker disease activity score: an objective tool for monitoring rheumatoid arthritis? A systematic review and meta-analysis
Meta-analysis
Arthritis Care Res (Hoboken)28 Dec 2022
Influence of Social Support, Financial Status, and Lifestyle on the Disparity Between Inflammation and Disability in Rheumatoid Arthritis
Cohort study
Rheumatology (Oxford)23 Dec 2022
Incidence of septic arthritis in patients with ankylosing spondylitis and seropositive rheumatoid arthritis following TNF inhibitor therapy
Cohort study
Semin Arthritis Rheum23 Dec 2022
Healthcare resource utilization and costs in stable patients with rheumatoid arthritis: Comparing nurse-led and rheumatologist-led models of care delivery
Cohort study
Ann Rheum Dis21 Dec 2022
Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial
Cohort study
Rheumatology (Oxford)20 Dec 2022
The added value of predictive biomarkers in treat-to-target strategies for rheumatoid arthritis patients: a conceptual modelling study
Research article
Rheumatology (Oxford)19 Dec 2022
Efficacy of subcutaneous vs intravenous infliximab in rheumatoid arthritis: a post-hoc analysis of a randomized phase III trial
Secondary analysis
Ann Rheum Dis16 Dec 2022
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis
Meta-analysis
J Rheumatol15 Dec 2022
Predicting Disease Activity in Rheumatoid Arthritis With the Fibromyalgia Survey Questionnaire: Does the Severity of Fibromyalgia Symptoms Matter?
Cohort study
Semin Arthritis Rheum14 Dec 2022
Defining independence: A scoping review by the OMERACT patient perspective of remission in rheumatoid arthritis group
Research article
Joint Bone Spine13 Dec 2022
Clinical significance of tocilizumab-related neutropenia in patients with rheumatoid arthritis
Cohort study
Arthritis Rheumatol13 Dec 2022
The Role of Genetics in Clinically Suspect Arthralgia and Rheumatoid Arthritis Development: A Large Cross‐Sectional Study
Cross-sectional study
Arthritis Care Res (Hoboken)12 Dec 2022
Association Between Inflammation, Incident Heart Failure, and Heart Failure Subtypes in Patients With Rheumatoid Arthritis
Cohort study
Semin Arthritis Rheum9 Dec 2022
Patient global assessment is elevated by up to 5 of 10 units in patients with inflammatory arthritis who screen positive for fibromyalgia (by FAST4) and/or depression (by MDS2) on a single MDHAQ
Cross-sectional study
Semin Arthritis Rheum8 Dec 2022
Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C)
Cohort study
Arthritis Rheumatol7 Dec 2022
A Multicenter, Prospective, Randomized, Parallel‐Group Trial on the Effects of Temporary Methotrexate Discontinuation for One Week Versus Two Weeks on Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis
Randomized controlled trial
Ann Rheum Dis6 Dec 2022
Occupational inhalable agents constitute major risk factors for rheumatoid arthritis, particularly in the context of genetic predisposition and smoking
Case-control study
Ann Rheum Dis5 Dec 2022
Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial
Randomized controlled trial
Arthritis Care Res (Hoboken)5 Dec 2022
Cost‐Effectiveness of the Early Arthritis Clinic Organizational Model
Cohort study
Clin Exp Rheumatol4 Dec 2022
Factors affecting the discrepancy between patient and physician global assessment in early rheumatoid arthritis: The Ontario Best Practices Research Initiative
Cohort study
Rheumatology (Oxford)2 Dec 2022
Crystalline silica exposure in patients with rheumatoid arthritis and systemic sclerosis: a nationwide cross-sectional survey
Cross-sectional study
Ann Rheum Dis30 Nov 2022
Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis
Randomized controlled trial
Rheumatology (Oxford)28 Nov 2022
Prevalence and predictors of atlanto-axial subluxation in rheumatoid arthritis after 12-years’ follow-up (ESPOIR Cohort)
Cohort study
Rheumatology (Oxford)28 Nov 2022
Is the relationship between deprivation and outcomes in rheumatoid arthritis mediated by body mass index? A longitudinal cohort study
Cohort study
Rheumatology (Oxford)28 Nov 2022
Anti-protein arginine deiminase antibodies are distinctly associated with joint and lung involvement in rheumatoid arthritis
Cohort study
Arthritis Care Res (Hoboken)28 Nov 2022
Psychosocial Burden Predicts Sustained Remission in Early Rheumatoid Arthritis: Unraveling the Complex Interplay of Well‐Being and Disease Activity
Secondary analysis
Arthritis Care Res (Hoboken)26 Nov 2022
Unique Serum Immune Phenotypes and Stratification of Oklahoma Native American Rheumatic Disease Patients
Cross-sectional study
Clin Exp Rheumatol25 Nov 2022
Higher skin autofluorescence in individuals at risk for rheumatoid arthritis: results from a large population based cohort
Cross-sectional study
Semin Arthritis Rheum24 Nov 2022
Genetic link between rheumatoid arthritis and autoimmune liver diseases: A two-sample Mendelian randomization study
Research article
Clin Exp Rheumatol24 Nov 2022
Impact of disease duration on proteomic bioprofile and prognosis in rheumatoid arthritis patients
Cohort study
Rheumatology (Oxford)23 Nov 2022
Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritis
Diagnostic or prognostic study
Rheumatology (Oxford)22 Nov 2022
Disproportionate articular pain is a frequent phenomenon in rheumatoid arthritis and responds to treatment with sarilumab
Secondary analysis
Ann Rheum Dis21 Nov 2022
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
Research article
Rheumatology (Oxford)18 Nov 2022
HOXA5 is a key regulator of class 3 semaphorins expression in the synovium of rheumatoid arthritis patients
Mechanistic study

All 1,564 Briefs in ExploreShowing Briefs 1,401–1,440 of 1,564, newest first